Key Financial Figures - Standalone (FY26)

  • Total Income: Rs 4,049.20 lakh
  • Total Expenses: Rs 3,917.51 lakh
  • Net Profit: Rs 131.70 lakh
  • EPS Basic: Rs 1.16
  • EPS Diluted: Rs 1.16
  • Equity Share Capital: Rs 1,140.00 lakh (Face value Rs 10/- each)
  • Other Equity: Rs 3,969.25 lakh
  • Total Assets: Rs 7,856.35 lakh

Key Financial Figures - Consolidated (FY26)

  • Total Income: Not separately quantified in disclosure
  • Net Profit: Rs 158.27 lakh (includes Rs 72.05 lakh share of profit from associate)
  • EPS Basic: Rs 0.92
  • EPS Diluted: Rs 0.92
  • Equity Share Capital: Rs 1,140.00 lakh
  • Other Equity: Rs 3,945.24 lakh
  • Total Assets: Rs 7,836.74 lakh
  • Investment in Associate: Rs 1,871.36 lakh (carrying value)

Audit Qualification Details

Nature of Qualification

Statutory auditors (Viren Gandhi & Co) issued a qualified opinion on consolidated financial results due to:

  • Inclusion of Rs 72.05 lakh share of profit from associate Spafax International Holding Limited and its subsidiary Spafax International Limited
  • This profit share was determined based on unaudited management accounts of Spafax Group
  • Audited financial statements/reviewed interim financial information of the associate were not available for audit verification

Impact Assessment

Management's View:

  • Impact is not precisely quantifiable without audited financial statements from Spafax Group
  • Maximum gross impact would be reversal of Rs 72.05 lakh from consolidated net profit if associate profit is excluded
  • Final impact subject to verification when audited financial statements become available

Auditors' Concurrence:

  • Agree with management's assessment that impact is not quantifiable
  • Confirm maximum gross impact would be reversal of Rs 72.05 lakh

Entities Involved

  • Spafax International Holding Limited (UK incorporated) became associate on February 23, 2026
  • Spafax International Limited (wholly owned subsidiary of above)
  • Investment made through Bharat Technology Limited (UK subsidiary)

Significant Events and Transactions

Share Warrant Conversions

  • During FY 2024-25, company issued 15,00,000 partly paid share warrants at Rs 330 per warrant (aggregating Rs 4,950.00 lakh)
  • During FY26: 2,60,000 warrants converted to equity shares
  • Additional 1,40,000 warrants converted during year
  • Balance 11,00,000 warrants lapsed in Q3 FY26, resulting in Rs 907.50 lakh credited directly to Retained Earnings

Subsidiary Sale

  • Completed sale of 50.01% shareholding in SKL India Private Limited on March 18, 2026
  • Advance amount of Rs 1,125.20 lakh received earlier adjusted against total sale consideration
  • SKL India ceased to be subsidiary from March 18, 2026

Associate Investment

  • Through wholly-owned subsidiary Bharat Technology Limited, company acquired stake in Spafax International Holding Limited in four tranches:
  • Tranche 1 (June 25, 2025): 9.90%
  • Tranche 2 (September 23, 2025): 19.80%
  • Tranche 3 (February 23, 2026): 29.71% (crossed 20% threshold, achieving significant influence)
  • Tranche 4 (March 09, 2026): 39.61%

Financial Impact Statement

Consolidated Results Impact

| Particulars | As Reported (Rs Lakhs) | Adjusted (if qualification applied) |

| Net Profit | 158.27 | Unascertainable (max impact: -72.05) |

| EPS | 0.92 | Unascertainable |

| Investment in Associate | 1,871.36 | Unascertainable (max impact: -72.05) |

| Net Worth | 5,085.24 | Unascertainable |

Standalone Results

  • No audit qualifications or modifications
  • Statutory auditors issued unmodified opinion on standalone financial results

Dates and Timelines

  • Financial Year End: March 31, 2026
  • Board Approval Date: May 28, 2026
  • Auditor's Report Date: May 28, 2026
  • Exchange Submission Date: June 19, 2026
  • SKL India Sale Completion: March 18, 2026
  • Spafax Associate Status Effective: February 23, 2026

Additional Information

  • No investor complaints pending as of March 31, 2026
  • Previous periods' figures have been regrouped/reclassified for comparability
  • Company engaged in manufacturing of automotive components and defence equipment
  • This is the first-time appearance of this audit qualification (Spafax became associate first time in FY26)